---
title: 'Targeted Therapy in Cancer: How Machine Learning is Helping Us Fight Smarter'
date: 2024-01-01
permalink: /posts/2024/01/targeted-therapy-cancer/
tags:
  - cancer
  - machine learning
  - targeted therapy
  - computational biology
---

## The Problem with Current Cancer Treatments

Cancer remains one of the most formidable challenges in modern medicine. While chemotherapy and conventional drugs have saved countless lives, they come with a critical limitation — they are not selective enough. Most cancer drugs target proteins shared by both cancer and healthy cells, causing collateral damage to normal tissue. This non-selectivity leads to debilitating side effects such as gastrointestinal distress, hair loss, and immune suppression. The urgent need for a smarter, more precise approach has driven scientists toward *targeted therapy* — a strategy that selectively destroys cancer cells while leaving healthy cells unharmed. Targeted therapy works by attacking proteins uniquely responsible for cancer cell growth, offering patients not just better survival odds, but a significantly improved quality of life.

## The Gap: Understanding Genetic Interactions

At the heart of targeted therapy lies a fascinating concept — genetic interactions. *Synthetic lethality* occurs when alterations in two genes together cause cell death, even though altering either gene alone is survivable. This makes synthetic lethal pairs powerful drug targets. Conversely, *synthetic viability* occurs when a second gene alteration rescues a sick cell, promoting survival and potentially driving drug resistance. Identifying these interactions is crucial for designing precision treatments — but doing so experimentally is expensive, time-consuming, and limited in scale. Computational methods that can predict these interactions reliably and at scale have been largely missing — until now.

## Our Results: MAGICAL — A Machine Learning Solution

To bridge this gap, we developed **MAGICAL** (Multi-class classifier for predicting Genetic Interactions using network properties), a machine learning model that predicts synthetic lethal and viable interactions using protein-protein interaction (PPI) network properties. Our key findings include:

- **Genetic interactions can be classified using network properties** — the position and connectivity of genes within the PPI network carry meaningful biological signals.
- **MAGICAL achieves ~80% accuracy using just five network properties** — demonstrating that a parsimonious, interpretable model can rival far more complex approaches.
- **Synthetic lethal pairs are distantly placed in different network modules** — meaning genes that kill cancer cells when co-altered tend to operate in separate biological pathways, a finding with profound implications for drug design.

## Broader Impact: Beyond Cancer

The implications of this work extend well beyond oncology. We have hosted **MAGICAL-DB**, a publicly accessible database containing millions of predicted genetic interactions. This resource serves as a hub for experimental biologists seeking proteins with redundant functions — opening doors to discoveries in developmental biology, aging research, and beyond. By enabling researchers to rapidly identify clinically relevant synthetic lethal and viable pairs, MAGICAL accelerates the path from computational prediction to therapeutic application. Ultimately, this work represents a step toward a future where cancer treatment is not just effective — but precise, personalized, and kinder to the patient.
